Dr. Malcolm Ross is the Managing Director of Generapharm-Consulting specialising in training, project management and research and development in the Generics industry.

Malcolm holds a B.Pharm and Ph.D from London University, was a lecturer in Pharmacognosy at the Welsh School of Pharmacy and a visiting Senior Lecturer in the Dept. of Chemistry at Bar Ilan University.

With over 30 years experience in the Pharmaceutical industry, the last 15 at corporate level, Malcolm has been intimately involved in strategy planning and analysis, pipeline management and related activities. He has worked in the UK, Israel, U.S.A, Canada, Poland and Switzerland. In his early career these activities were primarily US driven but, more recently, specific to the European market place. Previous roles include Head of Pharmaceutical Analytical Research at Teva Pharmaceuticals, VP R&D at Taro Pharmaceuticals, VP Science and Technology at PAR, Director of Research-Special Projects at Polpharma and etc.

Technically, Malcolm specialized in the development of finished dosage forms from both the analytical and formulation specialties and was responsible for establishing R&D in several companies in different international environments. Experience ranges from small CRO style to large corporate structures with multilevel reporting. 

Malcolm has been responsible for the development of over 40 generic Rx formulations and several OTC formulations including a number of innovative products. He is an acknowledged expert in pharmaceutical analysis and has had responsibility in areas of QA including worldwide auditing.

Over the years, in addition to R&D, Malcolm has had responsibility in areas of QA including worldwide auditing, and intellectual property, where he holds a number of innovative formulation patents. Recently he has been working in the CEE and has been involved with the introduction of Project Management systems and cultural issues related to change management and strategy.